Feedback Form
  • English
  • www.abcam.co.jp
Buying and contact info
AbpromiseSM

· Glycerol MSDS
· Sodium Azide MSDS

Western blot - Kallikrein 13 antibody - Catalytic domain (ab40959)
Western blot - Kallikrein 13 antibody - Catalytic domain (ab40959)
(enlarge)



Product Name 

Kallikrein 13 antibody - Catalytic domain

 

See all Kallikrein 13 antibodies (3)...

Product type 

Primary antibodies

Description 

Rabbit polyclonal to Kallikrein 13 - Catalytic domain

Immunogen 

Synthetic peptide based on the catalytic domain of human Kallikrein 13.

(Peptide available as ab43095.)

Reacts with 
(species key)

Hu

Specificity 

ab40959 reacts with human Kallikrein 13 and does not react with the human kallikreins (hK1-12, 14-15).

We have a range of domain specific antibodies for this target. For a full list please see all Kallikrein 13 antibodies

Tested applications 
(see key)

WB


Abreviews 

Customer reviews
(see key)


Read about Abreviews

Submit an Abreview

Be the first to review this antibody and earn 220 Abpoints.


Application notes 
(see key)

Recommended dilutions
WB: 1/1000 when using colorimetric substrates such as BCIP/NBT and 1/5000 for chemiluminescent substrates. Predicted molecular weight: 31 kDa. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.



Specific protocols
Recommended WB protocol

Cellular localization 

Secreted

Research areas 

Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Serine protease >> Kallikreins
Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> Kallikreins
Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> Kallikreins

Relevance 

The human tissue Kallikrein gene family encodes 15 serine proteases. All Kallikreins share structural similarities including cysteine residues, a catalytic triad of His, Asp, and Ser residues, typically five coding exons, and varied intron phases. Kallikreins are predominantly secreted as inactive zymogens prior to activation by cleavage of an N-terminal peptide and all function extracellularly. Kallikreins can be activated autocatalytically, via other Kallikreins, or additional proteases. While structurally similar, Kallikrein family members have distinct functions and have key roles in many physiological and pathological processes. Many human tissue Kallikreins also show promise as cancer biomarkers, which may facilitate earlier detection and characterization of many forms of cancer.

Kallikrein 13, also known as Kallikrein-like4 (